首页|疫苗国家监管体系临床试验监管相关板块的评估与思考

疫苗国家监管体系临床试验监管相关板块的评估与思考

扫码查看
2022年8月23日,世界卫生组织(WHO)宣布我国通过疫苗国家监管体系(NRA)评估,此次疫苗NRA评估指标大幅增加、内容更加全面、标准更加严格.本文介绍了WHO全球基准评估工具临床试验监管相关板块的要求,探讨了近年来临床试验监管的发展变化,以期为相关单位提升临床试验质量和完善临床试验监管提供参考.
Insights and Assessment on Clinical Trial Oversight Related Functions of National Regulatory Authority for Vaccines
On August 23,2022,the World Health Organization(WHO)announced that China had passed the assessment of National Regulatory Authority(NRA)for vaccines.The assessment indicators of the NRA for vaccines have significantly increased,with more comprehensive content and stricter standards.This article introduces the requirements of the WHO's Global Benchmarking Tool for clinical trial oversight related functions,and explores the changes and development of clinical trial oversight in recent years,aiming to offer reference for relevant entities to improve practice and oversight of clinical trials.

national regulatory authorityclinical trials oversightquality management system

杜娟、高天睿、崔孟珣、蓝恭涛

展开 >

湖南省药品审评与不良反应监测中心

国家药品监督管理局食品药品审核查验中心

国家药品监督管理局

疫苗国家监管体系 临床试验监管 质量管理体系

2024

中国食品药品监管
中国医药报社

中国食品药品监管

影响因子:0.099
ISSN:1673-5390
年,卷(期):2024.(3)
  • 12